Ушбу иш иқтибос қилган ишлар

262 та иш

Иш: Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

Hallmarks of Cancer: The Next Generation
Douglas Hanahan, Robert A. Weinberg
Шарҳ мақола201118 иқтибос
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Мақола20109 иқтибос
ABI
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail, Johanna A. Joyce
Шарҳ мақола20136 иқтибос
ABI
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano, Mohanraj Ramachandran, Anna Dimberg
Шарҳ мақола20196 иқтибос
ABI
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp +2
Шарҳ мақола20165 иқтибос
ABI
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth
Шарҳ мақола20115 иқтибос
ABI
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
Nazila Kamaly, Basit Yameen, Jun Wu +1
Шарҳ мақола20164 иқтибос
ABI
The tumor microenvironment’s role in the response to immune checkpoint blockade
Konstantinos Aliazis, Anthos Christofides, Rushil Shah +4
Шарҳ мақола20254 иқтибос
ABI
Cancer immunotherapy using checkpoint blockade
Antoni Ribas, Jedd D. Wolchok
Шарҳ мақола20183 иқтибос
ABI
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael Kalos, David M. Barrett +10
Мақола20133 иқтибос
ABI
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák
Шарҳ мақола20203 иқтибос
ABI
Long-term outcomes following CAR T cell therapy: what we know so far
Kathryn M. Cappell, James N. Kochenderfer
Шарҳ мақола20233 иқтибос
ABI
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Шарҳ мақола20213 иқтибос
ABI
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn, Vincenzo Bronte
Шарҳ мақола20153 иқтибос
ABI
The Acidic Tumor Microenvironment as a Driver of Cancer
Ebbe Boedtkjer, Stine F. Pedersen
Шарҳ мақола20193 иқтибос
ABI
Hypoxia-inducible factors: cancer progression and clinical translation
Elizabeth E. Wicks, Gregg L. Semenza
Шарҳ мақола20223 иқтибос
ABI
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan +10
Мақола20243 иқтибос
ABI
pH-Responsive polymers
Gökhan Kocak, Cansel Tuncer, Vural Bütün
Мақола20162 иқтибос
ABI
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer
Karen A. Autio, Robert Dreicer, Justine Anderson +13
Мақола20182 иқтибос
ABI
ATP-triggered anticancer drug delivery
Ran Mo, Tianyue Jiang, Rocco DiSanto +2
Мақола20142 иқтибос
ABI
A Phenylboronate‐Functionalized Polyion Complex Micelle for ATP‐Triggered Release of siRNA
Mitsuru Naito, Takehiko Ishii, Akira Matsumoto +3
Мақола20122 иқтибос
ABI
Acidic pH‐Responsive siRNA Conjugate for Reversible Carrier Stability and Accelerated Endosomal Escape with Reduced IFNα‐Associated Immune Response
Hiroyasu Takemoto, Kanjiro Miyata, Shota Hattori +5
Мақола20132 иқтибос
ABI
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
Xiaoding Xu, Phei Er Saw, Wei Tao +9
Мақола20172 иқтибос
ABI
Normalizing Tumor Vessels To Increase the Enzyme-Induced Retention and Targeting of Gold Nanoparticle for Breast Cancer Imaging and Treatment
Wei Xiao, Shaobo Ruan, Wenqi Yu +4
Мақола20172 иқтибос
ABI
Up-Regulation of PD-L1, IDO, and T <sub>regs</sub> in the Melanoma Tumor Microenvironment Is Driven by CD8 <sup>+</sup> T Cells
Stefani Spranger, Robbert M. Spaapen, Yuanyuan Zha +4
Мақола20132 иқтибос
ABI